Is Novartis AG halal to invest in?

As of July 2026, Novartis AG NVS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Novartis AG a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Novartis AG using these criteria to determine its compliance status.

Can Muslims buy shares of Novartis AG?

Muslim investors may consider investing in Novartis AG if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Novartis AG classified as HALAL?

Musaffa determines the Shariah status of Novartis AG by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Novartis AG updated?

The Shariah compliance status of Novartis AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Novartis AG become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Novartis AG?

You can check the latest Shariah compliance status of Novartis AG on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

NVS Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Novartis AG is classified as halal.

HALAL

Report Source: 2026 2nd Quarter Report

Novartis AG. Stock Analysis NVS

United States Health Care Mega Cap Report: Q2, 2026

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. The company is headquartered in Basel, Basel-Stadt and currently employs 75,267 full-time employees. The company went IPO on 2001-05-07. The firm develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The firm uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Key Statistics of Novartis AG (NVS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$158.03$160.34

Today's Open

$158.07

Volume

1.69M

P/E Ratio (TTM)

20.46

Financial Metrics & Statements of Novartis AG (NVS)

Super Investors Invested in Novartis AG (NVS)

FAQ's for Novartis AG (NVS)

As of July 2026, Novartis AG NVS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Novartis AG using these criteria to determine its compliance status.
Muslim investors may consider investing in Novartis AG if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Novartis AG by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Novartis AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Novartis AG on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.